Evidation Health taps into data people are already generating — from fitness trackers, smartwatches, glucose monitors, and health apps — to build a research platform that connects individuals with studies that match their health profiles. Founded in 2012 in San Mateo, California, the company has enrolled over five million people who consent to share their behavioral and biometric data in exchange for rewards and access to health programs.
The platform works by continuously collecting streams of data: step counts, sleep patterns, heart rate variability, blood glucose readings, and self-reported symptoms. Evidation’s data science team then applies machine learning models to detect digital biomarkers — patterns in daily behavior that correlate with disease onset, treatment response, or health deterioration. These insights help pharmaceutical companies design more efficient clinical trials and develop digital health measurements that regulators accept.
Evidation has partnered with major pharma and tech companies including Eli Lilly, Sanofi, and Apple on research studies ranging from COVID-19 symptom tracking to neurological disease detection. The company raised over $150 million in funding and operates with around 250 employees. Its Achievement platform rewards participants for healthy behaviors and research participation. What makes Evidation valuable to the life sciences industry is its ability to run virtual, decentralized studies at scale — recruiting participants, collecting real-world data, and delivering results faster and cheaper than traditional clinical research methods.
